ID   L1210
AC   CVCL_0382
SY   L 1210; L-1210; Leukemic 1210; Leukemia 1210; Leukemia L1210
DR   BTO; BTO:0000702
DR   CLO; CLO_0007139
DR   CLO; CLO_0007155
DR   CLO; CLO_0007156
DR   EFO; EFO_0005284
DR   MCCL; MCC:0000277
DR   CLDB; cl3111
DR   CLDB; cl3112
DR   CLDB; cl3113
DR   CLDB; cl3114
DR   CLDB; cl3115
DR   CLDB; cl4936
DR   CLDB; cl5219
DR   ATCC; CCL-219
DR   BCRC; 60049
DR   BCRJ; 0138
DR   BioSample; SAMN11397625
DR   CCRID; 1101MOU-PUMC000191
DR   CCRID; 4201MOU-CCTCC00203
DR   CCRID; 6101MOU-CERC000108
DR   ChEMBL-Cells; CHEMBL3308391
DR   ChEMBL-Targets; CHEMBL386
DR   CLS; 400257/p2482_L-1210
DR   DSMZ; ACC-123
DR   ECACC; 87092804
DR   GEO; GSM1112425
DR   GEO; GSM1112426
DR   ICLC; ATL99002
DR   KCB; KCB 200774YJ
DR   KCLB; 10219
DR   MeSH; D007939
DR   TKG; TKG 0154
DR   Wikidata; Q6456824
RX   PubMed=6970130;
RX   PubMed=18630317;
RX   PubMed=25277546;
RX   PubMed=31220119;
CC   Part of: ENCODE project mouse cell lines.
CC   Doubling time: 10-12 hours (CLS); ~50 hours (DSMZ).
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Omics: SNP array analysis.
CC   Derived from sampling site: Ascites.
CC   Breed/subspecies: DBA/2.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15,17
ST   Mouse STR 1-2: 16
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 12
ST   Mouse STR 2-1: 15
ST   Mouse STR 3-2: 13
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 13
ST   Mouse STR 6-4: 17
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 27,28
ST   Mouse STR 8-1: 16
ST   Mouse STR X-1: 27
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 23-09-21; Version: 25
RX   PubMed=6970130; DOI=10.1002/eji.1830101111;
RA   Conzelmann A., Pink R., Acuto O., Mach J.-P., Dolivo S., Nabholz M.;
RT   "Presence of T 145 on cytolytic T cell lines and their
RT   lectin-resistant mutants.";
RL   Eur. J. Immunol. 10:860-868(1980).
RX   PubMed=18630317; DOI=10.1093/jnci/36.3.405;
RA   Moore G.E., Sandberg A.A., Ulrich K.;
RT   "Suspension cell culture and in vivo and in vitro chromosome
RT   constitution of mouse leukemia L1210.";
RL   J. Natl. Cancer Inst. 36:405-413(1966).
RX   PubMed=25277546; DOI=10.1186/1471-2164-15-847;
RA   Didion J.P., Buus R.J., Naghashfar Z., Threadgill D.W.,
RA   Morse H.C. III, Pardo-Manuel de Villena F.;
RT   "SNP array profiling of mouse cell lines identifies their strains of
RT   origin and reveals cross-contamination and widespread aneuploidy.";
RL   BMC Genomics 15:847.1-847.11(2014).
RX   PubMed=31220119; DOI=10.1371/journal.pone.0218412;
RA   Almeida J.L., Dakic A., Kindig K., Kone M., Letham D.L.D., Langdon S.,
RA   Peat R., Holding-Pillai J., Hall E.M., Ladd M., Shaffer M.D., Berg H.,
RA   Li J., Wigger G., Lund S., Steffen C.R., Fransway B.B., Geraghty B.,
RA   Natoli M., Bauer B., Gollin S.M., Lewis D.W., Reid Y.A.;
RT   "Interlaboratory study to validate a STR profiling method for
RT   intraspecies identification of mouse cell lines.";
RL   PLoS ONE 14:E0218412-E0218412(2019).